1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Launchpad Grants in Eating Disorders Research is sponsored by Medical Research Council (UK). These grants fund research projects focused on understanding why eating disorders develop and what can be done to better prevent, diagnose, and treat them.
While based in the UK, one project specifically investigates whether AI can offer cost-effective, user-centered prevention interventions for eating disorders, applicable to digital therapeutics research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers, potentially with a focus on building networks for securing larger future funding. (Specific eligibility details would be on the funder's website). Confirm the full requirements in the official notice before applying.
The current listing shows over £700,000 invested across eight projects (approx. $885,000 USD). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Launchpad Grants in Eating Disorders Research is funded by Medical Research Council (UK). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article